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1. Introduction
Contagious bovine pleuropneumonia (CBPP) is a severe
respiratory disease that is widespread in sub-Saharan
Africa. CBPP is caused by Mycoplasma mycoides subsp.
mycoides (Mmm) a species belonging to the so-called
‘Mycoplasma mycoides cluster’. Mmm is characterized by
limited genetic diversity compared to other cluster
members (Fischer et al., 2012). CBPP is listed as a disease
of major importance by the OIE and the FAO and AU-IBAR
consider improved diagnostic tests and vaccines for CBPP
to be a research priority.
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A B S T R A C T
Contagious bovine pleuropneumonia (CBPP), caused by Mycoplasma mycoides subsp.
mycoides (Mmm) is a severe cattle disease, present in many countries in sub-Saharan
Africa. The development of improved diagnostic tests and vaccines for CBPP control
remains a research priority. Polyacrylamide gel electrophoresis and mass spectrometry
were used to characterize the Triton X-114 soluble proteome of nine Mmm strains isolated
from Europe or Africa. Of a total of 250 proteins detected, 67 were present in all strains
investigated. Of these, 44 were predicted to be lipoproteins or cytoplasmic membrane-
associated proteins and are thus likely to be members of the core in vitro surface
membrane-associated proteome of Mmm. Moreover, the presence of all identiﬁed proteins
in other ruminant Mycoplasma pathogens were investigated. Two proteins of the core
proteome were identiﬁed only in other cattle pathogens of the genus Mycoplasma pointing
towards a role in host–pathogen interactions. The data generated will facilitate the
identiﬁcation and prioritization of candidate Mycoplasma antigens for improved control
measures, as it is likely that surface-exposed membrane proteins will include those that
are involved in host–pathogen interactions.
 2013 The Authors. Published by Elsevier B.V. 
Abbreviations: CBPP, contagious bovine pleuropneumonia; Mmm,
coplasma mycoides subsp. mycoides; MS, mass spectrometry.
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I. Krasteva et al. / Veterinary Microbiology 168 (2014) 116–123 117The acute phase of the disease is characterized by a
leural pneumonia with a mortality reaching up to 60%
hen introduced in naı¨ve populations (Huebschle et al.,
006). A proportion of infected animals progress into a
hronic phase, with sequestered areas of necrotic lung
ssue harbouring live bacteria (Nicholas and Bashiruddin,
995). Acute disease correlates with elevated serum levels
f pro-inﬂammatory cytokines such as TNFa (Sacchini
t al., 2012), while the protective arm of immunity has not
een identiﬁed yet (Sacchini et al., 2011). CBPP was
radicated from developed countries, mainly by using
ovement control, culling of infected herds, quarantine
nd vaccination (Fisher, 2003; Provost, 1996; Thiaucourt
t al., 2003). However, in many regions of Africa, the lack of
nancial resources for compensating farmers and main-
ining functional veterinary services, cultural perceptions
nd pastoralism, render CBPP control, based on such
ontrol measures, neither feasible nor practical (Thiau-
ourt et al., 2004). The current live vaccine (derivatives of
mm strain T1) is characterized by limited efﬁcacy,
ccasional side effects at the site of injection and the need
f a cold chain (Tulasne et al., 1996). Moreover, the OIE-
ecognized assays for CBPP diagnostics (cELISA and CFT)
lso have shortcomings with respect to their sensitivities
arobela-Raborokgwe et al., 2003). Therefore, there is an
rgent need for improved vaccines and diagnostics,
uitable for the African continent. However, a prerequisite
r the development of improved control measures is an
creased understanding of host–pathogen interactions
nd the bacterial molecules involved. Molecules compris-
g the Mycoplasma surface proteome, such as lipoproteins
re likely to be of importance in such interactions
rowning et al., 2011). Currently, our understanding of
e composition of the surface proteome of Mmm is rather
mited. A characterization of the surface located molecules
ould assist in prioritizing candidate antigens and would
rovide information regarding molecules of importance in
e pathogenesis.
Triton X-114 fractionation has been shown to be a
owerful tool for enrichment of membrane proteins in
ycoplasma spp. and other bacteria (Goncalves et al., 1998;
asebe et al., 2007; Meens et al., 2006; Neyrolles et al.,
999). Previous studies using Triton X-114 partitioning
long with mAb gold labelling and electron microscopy
emonstrated the membrane localization of the Mmm
irulence factor GlpO (Pilo et al., 2005) and the variable
urface protein, Vmm (Persson et al., 2002). In a recent
tudy, mass spectrometry (MS) in combination with two-
dimensional gel electrophoresis (2-DGE) and immunoblot-
ting were used in order to identify immunogenic Mmm
proteins (Jores et al., 2009). However, no lipoproteins were
identiﬁed in that study; possibly because no enrichment of
membrane proteins was made prior to the 2-DGE.
Additionally, protein hydrophobicity may have also pre-
cluded separation of insoluble proteins in the ﬁrst
dimension (isoelectric focusing).
Here we describe the application of Triton X-114
extraction, SDS-polyacrylamide gel electrophoresis (PAGE)
and liquid chromatography–electrospray ionization tan-
dem mass spectrometry analysis (LC–ESI-MS/MS) for the
characterization of the in vitro surface proteome of nine
Mmm strains originating from Europe and Africa. Addi-
tionally, the presence of gene homologs of the detected
proteins in other Mycoplasma ruminant pathogens was
investigated.
2. Materials and methods
2.1. Mycoplasma strains and growth conditions
The nine Mycoplasma strains used are listed in Table 1.
Aliquots of frozen stock cultures (1.8 ml) were inoculated
and subsequently grown in 10 ml of PPLO medium (Difco,
UK), supplemented with fresh yeast extract, 15% horse
serum (Sigma–Aldrich, UK) and Penicillin G potassium
200 IU/ml at 37 8C in an atmosphere containing 5% CO2 to
logarithmic phase for 48–72 h. Cells were harvested by
centrifugation at 9000  g at 4 8C for 40 min and washed
three times with a serum-free semi-deﬁned medium
(Ramirez et al., 2008). Cell pellets were re-suspended in
200 ml semi-deﬁned medium and incubated at 37 8C
overnight until log-phase. Following centrifugation as
described above, cell pellets were washed three times with
PBS and after a ﬁnal centrifugation the cell pellets and
supernatants were stored separately at 70 8C until
further use.
Total protein (mg/ml) of the pelleted cells was
determined using Pierce BCA Protein Assay Kit (Thermo
Scientiﬁc, UK) according to manufacturer’s instructions.
2.2. Enrichment of Mycoplasma membrane associated
proteins using Triton X-114
Triton X-114 detergent phase fractionation was per-
formed as described previously (Wise et al., 1995). Brieﬂy,
cell pellets (1 mg of Mmm protein) were re-suspended in
able 1
ycoplasma mycoides subsp. mycoides strains used in this study.
Strain name Country of origin Year of isolation Host Reference
PG1 Africa 1931 Cattle Cheng et al. (1995)
B17/90 Chad 1967 Cattle Cheng et al. (1995)
T1/44 Tanzania 1951 Vaccine strain Yaya et al. (2008)
Afade´ Cameroon 1968 Cattle Cheng et al. (1995)
170 Italy 1992 Cattle Goncalves et al. (1998)
57/13 Italy 1992 Cattle Goncalves et al. (1998)
Caprivi Namibia 2003 Cattle Scacchia et al. (2007)
95 Italy 1992 Cattle Goncalves et al. (1998)PB90 Portugal 1990 Cattle Goncalves et al. (1998)
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I. Krasteva et al. / Veterinary Microbiology 168 (2014) 116–1231180 ml of ice-cold TS buffer (154 mM NaCl, 10 mM Tris,
 7.4) supplemented with protease inhibitor (complete,
TA-free, Roche Diagnostics, Germany) followed by the
dition of 100 ml ice cold 10% (v/v) TX-114 (Sigma–
drich, UK). The pellets were thoroughly dissolved by
rtexing at 4 8C for 1 h. After centrifugation at 12,000  g
 4 8C for 5 min the supernatants were transferred to a
w tube, incubated at 37 8C for 5 min and then
ntrifuged at 8000  g at room temperature for 3 min
 separate the phases (aqueous and detergent phases).
e aqueous phase was discarded and ice-cold TS
ffer with protease inhibitor was added to detergent
ase to a ﬁnal volume of 1 ml. The solution was mixed
 pipetting and incubated on ice for 5 min, then
nsferred to 37 8C and incubated for 5 min, centrifuged
 8000  g at room temperature for 3 min to separate
e phases (aqueous and detergent phases). Again the
ueous phase was discarded and 900 ml ice-cold TS
ffer with protease inhibitor was added to the detergent
ase. The phase separation step was repeated once
ore. After the ﬁnal separation, 900 ml ice-cold methanol
as added to the detergent phase and the samples
ere stored at 70 8C overnight. Following overnight
cubation the samples were centrifuged at 12,000  g at
C for 10 min. The pellets containing the enriched
embrane proteins were re-suspended in Laemmli
mple buffer (Sambrook and Russell, 2001). Total
otein (mg/ml) was determined using the Pierce
0 nm Protein Assay Kit (Thermo Scientiﬁc, UK)
cording to the manufacturer instructions. Three pre-
rations (biological replicates) were done per Mmm
rain in order to test the variation of the total protein
ount obtained after enrichment.
. Boiling preparation of Mycoplasma proteins
Mycoplasma cells were grown as described above and
lleted at 10,000  g for 10 min. The supernatant was
scarded and the pellets were re-suspended in Laemmli
mple buffer (Sambrook and Russell, 2001) before
cubation at 95 8C for 4 min. All protein preparations
ere done in triplicates (biological replicates).
. One-dimensional SDS-PAGE and trypsin digestion
One-dimensional SDS-PAGE separation of the proteins
m one biological replicate was performed according to
ndard protocols (Sambrook and Russell, 2001). Brieﬂy,
proximately 4 mg total protein was loaded on a
scontinuous Tris/glycine SDS-PAGE mini-gel (4% stack-
g gel; 12% resolving gel) and proteins were separated at
0 V for 90 min using a Mini-ProteanTM II Dual Slab Cell
ioRad Laboratories, UK). Resolved proteins were visua-
ed using SimplyBlue Safe StainTM (Invitrogen, UK). The
l was sliced horizontally from top to bottom to yield
ries of approximately 25 equal slices, 2.5 mm wide. The
ces were then subjected to standard in-gel de-staining,
duction, alkylation and trypsin digestion as described
eviously (Shevchenko et al., 1996). Protein samples were
nsferred to HPLC vials and were stored at 4 8C until
rther use.
2.5. Liquid chromatography–electrospray ionization tandem
mass spectrometry (LC–ESI-MS/MS) analysis
Liquid chromatography (LC) was performed using an
Ultimate 3000 nano-HPLC system (Dionex, US) interfaced
directly with a 3-D high capacity ion trap tandem mass
spectrometer (amaZon-ETDTM, Bruker Daltonics, UK) via a
low-volume (50 ml min1 maximum) stainless steel micro-
sprayer (Agilent Technologies, cat. no. G1946-20260) and
electrospray ionization (ESI). LC–ESI-MS/MS was performed
as described previously (Batycka et al., 2006). Each trypsin
digest was analyzed trice. Deconvoluted MS/MS data were
submitted to an in-house MASCOT server and searched
against the fully annotated genome of Mmm strain PG1. The
analysis of the MS/MS data was performed in accordance
with published guidelines (Taylor and Goodlett, 2005).
Fixed (carbamidomethyl ‘‘C’’) and variable modiﬁcations
(oxidation ‘‘M’’ and deamidation ‘‘N,Q’’) were selected and
peptide and fragment mass tolerance values set at 0.5 Da (#
13C = 1) and 0.5 Da respectively allowing for a single missed
cleavage. Molecular weight search (MOWSE) scores and
percentage coverage values attained for individual protein
identiﬁcations were inspected manually and considered
signiﬁcant only if (a) a minimum of two peptides were
matched for each protein and (b) each peptide contained an
unbroken ‘‘b’’ or ‘‘y’’ ion series of a minimum of four
contiguous amino acid residues.
Both Mascot (Matrix Science) and the Proteinscape
(Bruker) suite of MS data analysis programs generated
both molecular weight and isoelectric point values
nominally. However, molecular weight and isoelectric
point values might vary between multiple entries of the
same protein in a redundant database.
2.6. In silico analysis for predicting subcellular location and
presence of homologs
Prediction of N-terminal signal peptides for lipopro-
teins i.e. cleavage sites for signal peptidase II was done
using LipoP v 1.0 server (Rahman et al., 2008) while pSORT
v 3.0.2 (advanced gram staining setting for ‘negative
without outer membrane’) (Yu et al., 2010) was used to
predict subcellular location of the remaining proteins.
Using the advanced gram staining ‘negative without outer
membrane’ the following localizations are scored in the
ﬁnal output: cytoplasmic, cytoplasmic membrane, extra
cellular or unknown. For comparison to the identiﬁed
proteins, a similar prediction was done screening the
entire genome of Mmm strain PG1.
Homologs to all the identiﬁed Mmm proteins were
searched in the genomes of Mycoplasma mycoides subsp.
capri (GM12 and 95010), M. leachii (PG50 and 99/014/6), M.
feriruminatoris (G5847), M. capricolum subsp. capricolum
(ATCC 27343), M. bovis (PG45 and Hubei-1) and M.
agalactiae (PG2 and 5632) using Molligen (http://
www.cbib.u-bordeaux2.fr/outils/molligen/). The search
tool and the Molli60 substitution matrix were used, which
has been reported to improve the clustering of homologous
proteins (Lemaitre et al., 2011). An e-value lower or equal
to 1015 and a minimum of 30% sequence similarity were
required for a protein to be considered a homolog.
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.1. Enrichment of Mycoplasma mycoides subsp. mycoides
embrane proteins
Mean protein amounts ranging between 11 and 19 mg
ere obtained after membrane speciﬁc enrichment using
riton X-114 from 1 mg of Mycoplasma mycoides subsp.
ycoides (Mmm) protein pellets (Supplementary Table S1).
he results were comparable in three independent
iological replicates. The one-dimensional SDS-PAGE
anding pattern differed between the membrane-speciﬁc
nrichment and the simple boiling method for protein
xtraction (Supplementary Fig. S1). All protein prepara-
ons were done in triplicates (biological replicates) from
hich identical band patterns were obtained (data not
hown).
Supplementary material related to this article can be
und, in the online version, at http://dx.doi.org/10.1016/
vetmic.2013.10.025.
.2. Identiﬁcation of Mmm proteins using LC–ESI-MS/MS
In total 250 different Mycoplasma proteins were identi-
ed by LC–ESI-MS/MS analysis. MOWSE scores and percen-
ge sequence coverage obtained from the Mmm PG1
ASCOT database for the identiﬁed proteins are presented
 Supplementary Table S2. Of the identiﬁed proteins, 67
ere present in all Mmm strains tested (Fig. 1A). The PG1
enome Locus Tags of these proteins were: MSC_0005,
SC_0011, MSC_0013, MSC_0039, MSC_0065, MSC_0079,
SC_0103, MSC_0104, MSC_0108, MSC_0111, MSC_0130,
SC_0158, MSC_0240, MSC_0263, MSC_0265, MSC_0266,
SC_0267, MSC_0271, MSC_0292, MSC_0397, MSC_0405,
SC_0431, MSC_0457, MSC_0480, MSC_0570, MSC_0575,
SC_0582, MSC_0598, MSC_0606, MSC_0608, MSC_0609,
SC_0619, MSC_0624, MSC_0625, MSC_0627, MSC_0635,
SC_0671, MSC_0679, MSC_0707, MSC_0710, MSC_0711,
SC_0712, MSC_0716, MSC_0749, MSC_0757, MSC_0775,
MSC_0776, MSC_0790, MSC_0804, MSC_0831, MSC_0837,
MSC_0860, MSC_0873, MSC_0889, MSC_0893, MSC_0911,
MSC_0916, MSC_0946, MSC_0957, MSC_0973, MSC_0980,
MSC_0992, MSC_0993, MSC_1006, MSC_1007, MSC_1021,
MSC_1066.
Supplementary material related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.vetmic.2013.10.025.
The number of proteins identiﬁed per individual strain
ranged between 112 proteins in Mmm 170 up to 190 in
Mmm T1/44 (Fig. 1B). The in silico determined molecular
masses and isoelectric points (pI) ranged between 6.3 kDa–
226.8 kDa and pH 4.6–11.6 respectively (Supplementary
Table S2).
3.3. In silico prediction of the subcellular location of the
identiﬁed proteins
Among the 250 Mycoplasma proteins detected, 23 were
predicted to be lipoproteins using LipoP v 1.0 server
(Rahman et al., 2008) while 97 membrane proteins, 80
cytoplasmic and two extracellular proteins were predicted
using pSORT v 3.0.2 (Yu et al., 2010). The subcellular
location could not be speciﬁed for 48 proteins. The
distribution of the different protein types (i.e. lipoproteins,
cytoplasmic membrane, cytoplasmic, extra cellular, and
unknown) is presented in Fig. 1.
In general, the predicted membrane-associated pro-
teins (membrane proteins and lipoproteins) were larger
than the cytoplasmic proteins with a molecular mass
ranging between 6.4 kDa–226.8 kDa (mean 55.1 kDa) and
8.9 kDa–120.8 kDa (mean 38.1 kDa), respectively (Fig. 2).
Among the identiﬁed proteins the percentage of
predicted membrane-associated proteins ranged from
42% to 58% for Mmm B17 and Caprivi, respectively. For
PG1, 57% of the identiﬁed proteins were predicted to be
membrane-associated while the corresponding percentage
of membrane-associated proteins within the genome of
PG1 was predicted to be 26%.
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I. Krasteva et al. / Veterinary Microbiology 168 (2014) 116–123120The majority of the lipoproteins (n = 16) were detected
 all nine Mmm strains, however a number of lipoproteins
ere detected only in certain Mmm strains; MSC_1005,
SC_0364 and MSC_0897 were detected only in three
mm strains (Supplementary Table S2) while MSC_0847
as detected only in strain T1/44. Interestingly, three of
e latter (MSC_1005, MSC_0364 and MSC_0847) are
notated as putative variable prolipoproteins (Westberg
 al., 2004).
When comparing Mmm strains isolated in Africa (PG1,
7/90, T1/44, Afade´ and Caprivi) to strains isolated in
rope (170, 57/13, 95 and PB90) only one protein i.e.
olipoprotein B (PG1 locus tag MSC_0519) was detected
 all African strains while missing in all European strains.
 other differences between African and European strains
ere detected in this analysis.
Among the Mmm ﬁeld strains i.e. B17/90, Afade´ and
privi, one protein, annotated as ribonucleotide-dipho-
hate reductase beta subunit (locus tag MSC_0855), was
esent, which was not detected in the remaining strains.
wever, this protein was predicted to be of cytoplasmic
igin.
. Comparison of the in vitro core surface proteome with the
edicted membrane proteome
From the Triton X-114 membrane speciﬁc enrichment
d LC–ESI-MS/MS analysis, in total 67 proteins were
entiﬁed that were present in all nine Mmm strains
vestigated in this study. Among these proteins, 66%
 = 44) were predicted to be membrane-associated (mem-
ane proteins or lipoproteins) using LipoP v 1.0 server
ahman et al., 2008) and pSORT v3 (Yu et al., 2010).
enty-eight membrane proteins and 16 lipoproteins were
esent in all nine strains investigated, representing the in
ro core surface proteome. The identiﬁed proteins
present 12.5% and 41% of the PG1 predicted membrane
d lipoproteins, respectively. Among these, glycosyltrans-
rase (MSC_0108), Lipoprotein Q (MSC_1021) and immu-
dominant protein P72 precursor (MSC_0240) were found.
tably, other immunogenic proteins i.e. PG1 locus tags:
SC_0263, MSC_0265, MSC_0266, MSC_0267 and
SC_0679 were among the cytoplasmic proteins detected
in all nine strains. An additional 69 membrane proteins and
seven lipoproteins were present in fewer than nine strains
i.e. not within the core surface proteome.
3.5. Detection of homologs of the genes encoding identiﬁed
Mmm proteins in other pathogenic Mycoplasma of cattle
None of the 250 identiﬁed Mmm proteins were unique
to M. mycoides subsp. mycoides when searching for
homologs in other ruminant Mycoplasma sp. genomes
using the selection criteria mentioned in Section 2
(Supplementary Table S3). In total, 124 proteins had
homologs in all investigated species i.e. Mycoplasma
mycoides subsp. capri, M. leachii, M. feriruminatoris, M.
capricolum subsp. capricolum, M. bovis and M. agalactiae.
Two proteins encoded by the genes MSC_0431 and
MSC_0752 have a homolog only in the closely related
cattle pathogen M. leachii, while a homolog of MSC_0570
was present in M. capricolum subsp. capricolum and M.
leachii. Moreover, the putative variable prolipoprotein
(locus tag MSC_0364) has a homolog only in M. bovis. The
remaining proteins were present in one or more members
of the ‘Mycoplasma mycoides cluster’ as well as in M.
feriruminatoris (Fischer et al., 2013).
Supplementary material related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.vetmic.2013.10.025.
4. Discussion
The aim of this study was to comprehensively
characterize the in vitro surface proteome of Mycoplasma
mycoides subsp. mycoides (Mmm), the causative agent of
contagious bovine pleuropneumonia (CBPP), by membrane
speciﬁc enrichment using Triton X-114 and LC–ESI-MS/MS
analysis. Nine different Mmm strains isolated in Europe
and Africa from 1931 until 2003 were compared (Table 1).
The study was commenced in order to identify candidate
vaccine and diagnostic targets and to prioritize antigens for
future mutagenesis studies for an increased understanding
of host–pathogen interactions.
Protein partitioning using Triton X-114 is an effective
way to enrich membrane proteins (Goncalves et al., 1998;
Molecular mass (kDa) 
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I. Krasteva et al. / Veterinary Microbiology 168 (2014) 116–123 121asebe et al., 2007; Meens et al., 2006; Neyrolles et al.,
999). Here, a difference in 1D SDS-PAGE banding patterns
etween untreated cells i.e. boiling preparation and Triton
-114 enriched protein fractions, indicated a successful
nrichment of membrane proteins (Supplementary Fig.
1). In total 250 proteins were identiﬁed after Triton X-114
artitioning and LC–ESI-MS/MS analysis (Supplementary
able S2). The subcellular location of the proteins was
redicted using LipoP v 1.0 server and pSORT v 3.0.2. For
e individual Mmm strains the percentage of membrane-
ssociated proteins (membrane and lipoproteins) ranged
etween 42% and 58%. The corresponding percentage
ithin the genome of PG1 was 26%, thus indicating an
nrichment, however not exclusively of membrane pro-
ins. Further, due to inherent limitations of the software
sed for predicting subcellular locations (pSORT v 3.0.2),
e possibility that a number of membrane proteins may
ave been categorized as unknown cannot be excluded.
he fraction of enriched membrane-associated proteins
ight thus be higher.
Despite the fact that Mmm shows very little genetic
iversity (Fischer et al., 2012), differences in the in vitro
urface proteome are expected due to a number of factors,
uch as differences in expression patterns in biological
eplicates that are not identical, the absence of encoding
enes, the absence of transcription or sequence variation
etween homologous genes. Additionally, the presence of
ariable surface lipoproteins has been reported for Mmm
ersson et al., 2002). Indeed, three proteins annotated as
utative variable prolipoproteins (Westberg et al., 2004)
ere detected in three Mmm strains or less (Supplemen-
ry Table S3), conﬁrming the variable nature of their
xpression. Phenotypic switching in Mmm could thus
xplain the inability for the host to mount an appropriate
mune response after vaccination. Furthermore,
lthough the genetic sequence does not reveal any
dditional genes with alternative expression patterns
estberg et al., 2004), the presence of such entities
annot be excluded (Rosengarten and Wise, 1990). More-
ver, differences in strains originating from different
eographical locations have been reported. An 8.84 kb
enomic fragment encoding the gtsABC operon that is
resent in African strains, but absent in European strains
heng et al., 1995; Vilei et al., 2000) has been linked to
ifferences in virulence (Abdo et al., 1998). As expected,
e immunodominant prolipoprotein B, encoded by lppB
G1 locus tag MSC_0519) located within the 8.84 kb
egment was only detected in the African strains
vestigated in this study. GtsA was detected in all African
trains except in PG1, despite the presence of gtsA in its
enome. This might be attributed to low expression values
eyond the threshold of detection. The low expression
ight account for its reduced binding capacity to bovine
ells and attenuation of virulence (Bischof et al., 2008). We
id not detect gtsBC in European and African strains, which
as expected for the ﬁrst but not for the latter strains,
ince gtsBC are present in the genome of most African
mm strains investigated in this study (Vilei et al., 2000).
Strain-speciﬁc genes and reversible phase variation are
us important to consider during the screening for
iagnostic antigens and candidate vaccine molecules. For
the latter, a multi-component type of vaccine, incorporat-
ing steadily expressed units from multiple antigens might
be an option. The differences in in vitro expression of
surface proteins are likely to account for the conﬂicting
results obtained by bacterin type of vaccine experiments
for CBPP (Garba et al., 1986; Gourlay, 1975; Gray et al.,
1986). Here we characterized the in vitro core surface
proteome i.e. membrane and lipoproteins present in all
nine Mmm strains investigated. Forty-four such proteins
were found of which 28 were predicted membrane
proteins and 16 were predicted lipoproteins. Together
these membrane-associated proteins represent only 16.9%
of the predicted membrane-associated proteins within the
genome of PG1. More speciﬁcally, the membrane proteins
detected represented 12.5% of the PG1-predicted mem-
brane proteins while 41% of the predicted lipoproteins
within the PG1 genome were detected in all nine strains,
thus indicating that lipoproteins are easier to enrich using
Triton X-114. However, the data presented here have to be
weighted with respect to the detection limits of the
technique used. Consequently, low abundance proteins
might not have been detected. Here, 1 mg of protein was
used for the Triton X-114 enrichment. A signiﬁcant
increase in the amount of starting material might have
resulted in the detection of additional proteins only if the
ratio of low abundance to high abundance proteins would
change towards low abundance proteins.
Mycoplasma molecules to be incorporated in diagnostic
assays or vaccine formulations should be relatively
conserved and be present in all circulating Mmm. A
number of the proteins identiﬁed within the core surface
proteome (e.g. MSC_0079, MSC_1021 [identical to
MSC_1046 LppQ], MSC_0108, MSC_0240 and MSC_0431)
are immunogenic and have previously been investigated
for their diagnostic potential and for use in a novel subunit
vaccine (Bruderer et al., 2002; Gantelius et al., 2010;
Hamsten et al., 2010; Naseem et al., 2010). Additionally, a
number of previously identiﬁed immunogenic cytoplasmic
molecules i.e. MSC_0263, MSC_0265, MSC_0266,
MSC_0267 and MSC_0679 (Jores et al., 2009; Naseem
et al., 2010) were detected in all nine Mmm strains.
However, other immunogenic molecules e.g. LppA
(MSC_0014) (Cheng et al., 1996) and LppC (MSC_0177)
(Pilo et al., 2003) were detected in only a subset of the
strains (LppA) or were not detected at all (LppC). The
conﬁrmed genomic presence of these genes in numerous
Mmm strains (Cheng et al., 1996; Pilo et al., 2003) does
indicate that there might be differences between the in
vitro and the in vivo surface proteome, suggestively due to
differences in growth conditions, growth phase or due to
host-dependent factors. However, although valuable, data
regarding Mmm protein expression in vivo is lacking due to
the difﬁculty in evaluating this aspect in cattle. Alter-
natively, the in vivo expressed antigens can be monitored
through the analysis of the host humoral immune response
to in silico selected, in vitro expressed and puriﬁed Mmm
antigens. In recent studies, the serological responses to
Mmm proteins were characterized (Hamsten et al., 2009;
Jores et al., 2009; Naseem et al., 2010). Among these, 31
were detected in this study, whereof 16 were identiﬁed in
the core surface proteome. The rather low coherence does
in
pr
ca
Se
pr
ev
CB
M
de
an
ot
as
et
an
an
no
Th
fo
va
pr
an
re
ch
m
ch
Co
in
Ac
He
Fe
m
00
th
Fis
M
Ge
Re
Ab
Ba
Bis
Bro
I. Krasteva et al. / Veterinary Microbiology 168 (2014) 116–123122deed support the concept of different in vivo and in vitro
otein expression proﬁles.
The proteins comprising the surface core proteome are
ndidate molecules for next generation diagnostic assays.
ra from infected animals should be investigated for the
esence of antibodies directed against them in order to
aluate their potential in improved diagnostic assays.
Vaccination is the most cost effective control option for
PP in sub-Saharan Africa. Systematic screening for target
ycoplasma molecules is an important step towards the
velopment of a subunit vaccine. In this study, most
tigens identiﬁed were homologous to proteins found in
her members of the ‘Mycoplasma mycoides cluster’ as well
 in the recently described species M. feriruminatoris (Jores
 al., 2013). Only three molecules (MSC_0431, MSC_0752
d MSC_0570) could be shown to share homology with
tigens in the closely related cattle pathogen M. leachii but
t with most of the other species comprising the cluster.
ese antigens are likely to include molecules responsible
r host tropism and are thus interesting candidates for
ccines and merit further evaluation. Therefore the
esence of antibodies speciﬁc for these proteins in immune
imals, as well the ability of knock out mutants with
spect to binding to host cells should be investigated to
aracterize their role in host–pathogen interactions.
Moreover, a progressive characterization of the surface
olecules should include those comprising the polysac-
aride capsule of Mmm.
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